直肠癌术前IMRT技术的临床应用进展

doi:10.3760/cma.j.issn.1004-4221.2016.02.023

Abstract
Figure/Table
References()
Related Citation (15)
Read Tracking
Download Tracking

[1]Sauer R,Becker H,Hohenberger W,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J].N Engl J Med,2004,351(17):1731-1740.DOI:10.1056/NEJMoa040694.
[2]Gérard JP,Conroy T,Bonnetain F,et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T_3-4 rectal cancers:results of FFCD 9203[J].J Clin Oncol,2006,24(28):4620-4625.DOI:10.1200/JCO.2006.06.7629.
[3]Braendengen M,Tveit KM,Berglund A,et al. Randomized phase Ⅲ study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer[J].J Clin Oncol,2008,26(22):3687-3694.DOI:10.1200/JCO.2007.15.3858.
[4]Roh MS,Colangelo LH,O′Connell MJ,et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum:NSABP R-03[J].J Clin Oncol,2009,27(31):5124-5130.DOI:10.1200/JCO.2009.22.0467.
[5]Arbea L,Ramos LI,Martínez-Monge R,et al. Intensity-modulated radiation therapy (IMRT) vs.3D conformal radio-therapy (3DCRT) in locally advanced rectal cancer (LARC):dosimetric comparison and clinical implications[J].Radiat Oncol,2010,5(1):17.DOI:10.1186/1748-717X-5-17.
[6]Hu K,Pang TT,Yang B,et al. Dosimetric analysis of preoperative three-dimensional conformal and preoperative intensity modulated radiotherapy for rectal cancer[J].Chin J Radiol Med Prot,2010,30(3):310-313.DOI:10.3760/cma.j.issn.0254-5098.2010.03.021.
[7]Mok H,Crane CH,Palmer MB,et al. Intensity modulated radiation therapy (IMRT):differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma[J].Radiat Oncol,2011,6(1):63.DOI:10.1186/1748-717X-6-63.
[8]Samuelian JM,Callister MD,Ashman JB,et al. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer[J].Int J Radiat Oncol Biol Phys,2012,82(5):1981-1987.DOI:10.1016/j.ijrobp.2011.01.051.
[9]Parekh A,Truong MT,Pashtan I,et al. Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer[J].Gastrointest Cancer Res,2013,6(5-6):137-143.
[10]Vazquez MD,Ferraris G,Bianchi A,et al. Clinical comparison of IMRT with 3D-CRT in preoperative chemoradiation therapy for locally-advanced rectal cancer (LARC)[J].Int J Radiat Oncol Biol Phys,2013,87(S2):S329.DOI:10.1016/j.ijrobp.2013.06.867.
[11]Garofalo M,Moughan J,Hong T,et al. RTOG 0822:A phase Ⅱ study of preoperative (PREOP) chemoradiotherapy (CRT) utilizing IMRT in combination with capecitabine (C) and oxaliplatin (O) for patients with locally advanced rectal cancer[J].Int J Radiat Oncol Biol Phys,2011,81(S2):S3-S4.DOI:10.1016/j.ijrobp.2011.06.008.
[12]Ren H,Jin J,Xiao Q,et al. Comparison of acute toxicities between IMRT and VMAT in preoperative concurrent chemoradiotherapy for rectal cancer[J].Chin J Radiat Oncol,2014,23(3):205-209.DOI:10.3760/cma.j.issn.1004-4221.2014.03.007.
[13]Li M,Gao H,Li GF,et al. Efficacy of preoperative concurrent chemoradiotherapy in treatment of locally advanced middle-low rectal cancer[J].Chin J Radiat Oncol,2014,23(4):286-290.DOI:10.3760/cma.j.issn.1004-4221.2014.04.003.
[14]Freedman GM,Meropol NJ,Sigurdson ER,et al. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer[J].Int J Radiat Oncol Biol Phys,2007,67(5):1389-1393.DOI:10.1016/j.ijrobp.2006.11.017.
[15]Ballonoff A,Kavanagh B,McCarter M,et al. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer:a phase Ⅱ trial[J].Am J Clin Oncol,2008,31(3):264-270.DOI:10.1097/COC.0b013e318161 dbd3.
[16]姚波,郑明民,张艳,等.低位直肠癌手术前后调强放疗同期希罗达化疗的初步比较[J].中华放射肿瘤学杂志,2010,19(1):72-73.DOI:10.3760/cma.j.issn.1004-4221.2010.01.027.
Yao B,Zheng MM,Zhang Y,et al. Comparative study of clinical efficacy between preoperative and postoperative intensity-modulated radiotherapy with oral capecitabine in low rectal cancer[J].Chin J Radiat Oncol,2010,19(1):72-73.DOI:10.3760/cma.j.issn.1004-4221.2010.01.027.
[17]Li JL,Ji JF,Cai Y,et al. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer:a phase Ⅱ trial[J].Radiother Oncol,2012,102(1):4-9.DOI:10.1016/j.radonc.2011.07.030.
[18]Yang YQ,Feng LCH,Jia QB,et al. Preliminary results of the prospective clinical trial of preoperative concomitant boost intensity-modulated radiotherapy in locally advanced rectal cancer[J].Chin J Radiol Med Prot,2013,33(5):512-515.DOI:10.3760/cma.j.issn.0254-5098.2013.05.014.
[19]Xiao L,Huang R,You KY,et al. Study on feasibility of preoperative neoadjuvant chemoradiotherapy based on volumetric modulated arc therapy for locally advanced rectal cancer[J].Chin J Radiat Oncol,2014,23(1):9-13.DOI:10.3760/cma.j.issn.1004-4221.2014.01.003.
[20]杨咏强,冯林春,王运来,等.VMAT应用于直肠癌术前同期加量放疗的剂量学研究[J].中华放射肿瘤学杂志,2014,23(5):400-401.DOI:10.3760/cma.j.issn.1004-4221.2014.05.008.
Yang YQ,Feng LCH,Wang YL,et al. Dosimetric study of preoperative volumetric intensity-modulated arc therapy for rectal cancer[J].Chin J Radiat Oncol,2014,23(5):400-401.DOI:10.3760/cma.j.issn.1004-4221.2014.05.008.
[21]Zhu J,Liu FQ,Gu WL,et al. Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage Ⅱ/Ⅲ rectal adenocarcinoma:results of a phase Ⅱ study[J].Radiat Oncol,2014,9(1):70.DOI:10.1186/1748-717X-9-70.
[22]Hernando-Requejo O,López M,Cubillo A,et al. Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation[J].Strahlenther Onkol,2014,190(6):515-520.DOI:10.1007/s00066-014-0650-0.
[23]Baglan KL,Frazier RC,Yan D,et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer[J].Int J Radiat Oncol Biol Phys,2002,52(1):176-183.DOI:10.1016/S0360-3016(01)01820-X.
[24]Robertson JM,Shn M,Yan D,et al. Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model[J].Int J Radiat Oncol Biol Phys,2010,77(1):66-72.DOI:10.1016/j.ijrobp.2009.04.048.
[25]Wong SJ,Winter K,Meropol NJ,et al. Radiation Therapy Oncology Group 0247:a randomized phase Ⅱ study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer[J].Int J Radiat Oncol Biol Phys,2012,82(4):1367-1375.DOI:10.1016/j.ijrobp.2011.05.027.
[26]Capirci C,Valentini V,Cionini L,et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer:long-term analysis of 566 ypCR patients[J].Int J Radiat Oncol Biol Phys,2008,72(1):99-107.DOI:10.1016/j.ijrobp.2007.12.019.
[27]Zorcolo L,Rosman AS,Restivo A,et al. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival:a meta-analysis[J].Ann Surg Oncol,2012,19(9):2822-2832.DOI:10.1245/s10434-011-2209-y.
[28]Maas M,Beets-Tan RGH,Lambregts DMJ,et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer[J].J Clin Oncol,2011,29(35):4633-4640.DOI:10.1200/JCO.2011.37.7176.
[29]Habr-Gama A,Gama-Rodrigues J,S o Juli o GP,et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation:impact of salvage therapy on local disease control[J].Int J Radiat Oncol Biol Phys,2014,88(4):822-828.DOI:10.1016/j.ijrobp.2013.12.012.
[30]Fu CG,Gao XH.Surgical treatment strategies for locally advanced rectal cancer after neoadjuvant radiation[J].Chin J Gastroint Surg,2013,16(6):513-517.DOI:10.3760/cma.j.issn.1671-0274.2013.06.005.
[31]Mohiuddin M,Regine WF,John WJ,et al. Preoperative chemoradiation in fixed distal rectal cancer:dose time factors for pathological complete response[J].Int J Radiat Oncol Biol Phys,2000,46(4):883-888.DOI:10.1016/S0360-3016(99)00486-1.
[32]Wiltshire KL,Ward IG,Swallow C,et al. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer:effect of dose escalation on pathologic complete response,local recurrence-free survival,disease-free survival,and overall survival[J].Int J Radiat Oncol Biol Phys,2006,64(3):709-716.DOI:10.1016/j.ijrobp.2005.08.012.